Alessandra Pavesio, SVP & Chief Science Officer at Bioventus Inc. (BVS), sold 433 shares at $11.99 ($5K) on 2022-02-14, disclosed to the SEC on 2022-02-16.
Scheduled sale ($5k) by SVP & Chief Science Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |